BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 20388399)

  • 21. Phytoestrogens induce differential effects on both normal and malignant human breast cells in vitro.
    Chen FP; Chien MH
    Climacteric; 2014 Dec; 17(6):682-91. PubMed ID: 24978400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells.
    Cos S; Fernández R; Güézmes A; Sánchez-Barceló EJ
    Cancer Res; 1998 Oct; 58(19):4383-90. PubMed ID: 9766668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of effect of the procarcinogenic 17β-estradiol on nutrient uptake by the MCF-7 breast cancer cell line.
    Nunes C; Silva C; Correia-Branco A; Martel F
    Biomed Pharmacother; 2017 Jun; 90():287-294. PubMed ID: 28365520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of lower concentrations of phytoestrogens on the effects of estradiol in breast cancer cells.
    Chen FP; Chien MH; Chern IY
    Climacteric; 2015; 18(4):574-81. PubMed ID: 25581323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin-like growth factor-1 and 17β-estradiol down-regulate prostate apoptosis response-4 expression in MCF-7 breast cancer cells.
    Casolari DA; Pereira MC; de Bessa Garcia SA; Nagai MA
    Int J Mol Med; 2011 Sep; 28(3):337-42. PubMed ID: 21567071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway.
    Sengupta K; Banerjee S; Saxena N; Banerjee SK
    Int J Oncol; 2003 Mar; 22(3):609-14. PubMed ID: 12579315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 17β-estradiol regulates cell proliferation, colony formation, migration, invasion and promotes apoptosis by upregulating miR-9 and thus degrades MALAT-1 in osteosarcoma cell MG-63 in an estrogen receptor-independent manner.
    Fang D; Yang H; Lin J; Teng Y; Jiang Y; Chen J; Li Y
    Biochem Biophys Res Commun; 2015 Feb; 457(4):500-6. PubMed ID: 25592968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
    Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 17β-estradiol-induced ACSL4 protein expression promotes an invasive phenotype in estrogen receptor positive mammary carcinoma cells.
    Belkaid A; Ouellette RJ; Surette ME
    Carcinogenesis; 2017 Apr; 38(4):402-410. PubMed ID: 28334272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of ER520, a candidate of selective estrogen receptor modulators, on in vitro cell growth, migration, invasion, angiogenesis and in vivo tumor xenograft of human breast cancer cells.
    Wang L; Wang Y; Du H; Jiang Y; Tang Z; Liu H; Xiang H; Xiao H
    Cancer Chemother Pharmacol; 2015 Dec; 76(6):1247-57. PubMed ID: 26464351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effects of 3,3'-diindolylmethane on epithelial-mesenchymal transition induced by endocrine disrupting chemicals in cellular and xenograft mouse models of breast cancer.
    Lee GA; Hwang KA; Choi KC
    Food Chem Toxicol; 2017 Nov; 109(Pt 1):284-295. PubMed ID: 28844962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in protein tyrosine phosphatase type IVA member 1 and zinc finger protein 36 C3H type-like 1 expression demonstrate altered estrogen and progestin effect in medroxyprogesterone acetate-resistant and estrogen-independent breast cancer cell models.
    Pennanen PT; Sarvilinna NS; Purmonen SR; Ylikomi TJ
    Steroids; 2009; 74(4-5):404-9. PubMed ID: 19146866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combinatory effects of phytoestrogens and 17beta-estradiol on proliferation and apoptosis in MCF-7 breast cancer cells.
    Schmidt S; Michna H; Diel P
    J Steroid Biochem Mol Biol; 2005 Apr; 94(5):445-9. PubMed ID: 15876409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physiologic levels of 2-methoxyestradiol interfere with nongenomic signaling of 17beta-estradiol in human breast cancer cells.
    Vijayanathan V; Venkiteswaran S; Nair SK; Verma A; Thomas TJ; Zhu BT; Thomas T
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2038-48. PubMed ID: 16609013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of single and repeated in vitro exposure of three forms of parabens, methyl-, butyl- and propylparabens on the proliferation and estradiol secretion in MCF-7 and MCF-10A cells.
    Wróbel A; Gregoraszczuk EŁ
    Pharmacol Rep; 2013; 65(2):484-93. PubMed ID: 23744433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Estrogen Receptor-Mediated Anti-Tumor Effects in U2OS Cells.
    Yang Z; Qian J; Yu W; Yang M; Liu B; Tao H
    Ann Clin Lab Sci; 2020 Nov; 50(6):747-753. PubMed ID: 33334789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA methylation of claudin-6 promotes breast cancer cell migration and invasion by recruiting MeCP2 and deacetylating H3Ac and H4Ac.
    Liu Y; Jin X; Li Y; Ruan Y; Lu Y; Yang M; Lin D; Song P; Guo Y; Zhao S; Dong B; Xie Y; Dang Q; Quan C
    J Exp Clin Cancer Res; 2016 Jul; 35(1):120. PubMed ID: 27461117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of 17 beta-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cells.
    Mirkin S; Wong BC; Archer DF
    Fertil Steril; 2005 Aug; 84(2):485-91. PubMed ID: 16084894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tight junction protein, claudin-6, downregulates the malignant phenotype of breast carcinoma.
    Wu Q; Liu Y; Ren Y; Xu X; Yu L; Li Y; Quan C
    Eur J Cancer Prev; 2010 May; 19(3):186-94. PubMed ID: 20215972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S; Krishnan AV; Feldman D
    Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.